Histosonics, Inc.
HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquify and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels.
5
Funding Rounds
$218.1m
Money raised
Overview
HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquify and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels.
Funding
Funding series
Funding Series Analysis
The company Histosonics, Inc. has raised a total of $164.13m in funding over 5 rounds.
Key Insights:
- HistoSonics August 2024 Series D Funding round: $102m
- HistoSonics , June 2020: $40m
- HistoSonics Series B round: $11.13m
- HistoSonics Series A round: $11m
- HistoSonics funding round, April 2019: $54m
HistoSonics August 2024 Series D Funding round
$102m
HistoSonics , June 2020
$40m
HistoSonics Series B round
$11.13m
HistoSonics Series A round
$11m
HistoSonics funding round, April 2019
$54m
Industries
Histosonics, Inc. is active in the following industries: